Supportive: oral or intravenous fluids, antipyretics (paracetamol 1 g every 6 hours), analgesia, antiemetics.
Pharmacological (adjust to culture and local resistance):
- Outpatient, mild to moderate: ciprofloxacin 500 mg twice daily for 7 days (or levofloxacin 750 mg daily for 5 days), or cefixime 400 mg daily for 10 days, or amoxicillin-clavulanate 625 mg three times daily for 10 to 14 days, or cotrimoxazole 960 mg twice daily for 14 days if the isolate is susceptible.
- Parenteral for severe disease, vomiting, pregnancy or sepsis: ceftriaxone 1 to 2 g IV daily, or gentamicin 5 mg/kg IV daily (with amoxicillin 1 g every 8 hours) or amikacin 15 mg/kg daily; switch to oral when afebrile for 24 to 48 hours; total 7 to 14 days.
- Extended-spectrum beta-lactamase producers: meropenem 1 g IV every 8 hours or ertapenem 1 g IV daily.
- Pseudomonas: piperacillin-tazobactam 4.5 g IV every 6 hours or ceftazidime 2 g IV every 8 hours.
- Children: ceftriaxone 50 to 75 mg/kg IV daily; oral cefixime 8 mg/kg daily or cefalexin 25 mg/kg twice daily, for 7 to 10 days.
- Pregnancy: admit; ceftriaxone 1 g IV daily until afebrile for 48 hours, then oral cefalexin 500 mg four times daily to complete 10 to 14 days, followed by nitrofurantoin 100 mg at night until delivery; avoid fluoroquinolones, doxycycline, and cotrimoxazole in the first trimester.
Procedures: relieve obstruction urgently by ureteric stent or percutaneous nephrostomy; drain abscesses above 3 to 5 cm; nephrectomy for emphysematous or xanthogranulomatous disease unresponsive to drainage.
Special groups: diabetes (glucose control, imaging), men (prostatitis, 14 days of therapy), catheterised patients (change catheter), HIV.
Red flags: hypotension, rigors with obstruction, persistent fever beyond 72 hours, pregnancy, gas on imaging.
Follow-up: culture again only if symptoms persist; urine culture after therapy in pregnancy; ultrasound to look for structural disease after the first childhood or male episode.